S&P 500 7522.53 -0.28%
NASDAQ 26060.62 -0.56%
TASI 10808.43 -0.42%
Oil (WTI) 71.83 -0.35%
Oil (Brent) 76.25 -0.07%
VIX 15.50 -2.15%
Gold 4115.00 -0.62%
USD/SAR 3.75 +0.01%

HCA Healthcare, Inc.

HCA · Healthcare · · USD
403.22 USD
0.00 (-1.42%)
● Updated 2026-07-10 18:08 Saudi Time ↻ Refresh
Short-term Mid-term Long-term

Fahodi Score SELL Short-term (Swing)

46
/ 100
Technical 50
Trend & RS 39
Momentum 34
Fundamental (0%) 51
Macro 65
Liquidity 41
ComponentScoreWeight
Technical 50.0 40%
Trend & RS 39.1 20%
Momentum 33.7 20%
Fundamental 51.3 0%
Macro 65.2 15%
Liquidity 40.6 5%

Trade Setup

Entry 403.69
Stop Loss 381.19 (5.6%)
Target 1 (1:1) 426.19 (+5.6%)
Target 2 (2:1) 448.69 (+11.2%)
ATR(14) 11.25 (2.8%)
Risk per Share 22.50
Reward:Risk 2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor Score Z Bar
Value 77.3 +1.09
Momentum 33.7 -0.65
Quality 23.7 -1.05
Composite 44.9

Quality Scores

Piotroski F-Score 4 /9 — Average
✓ ✗ ✗ ✗ ✗ ✗ ✓ ✓ ✓
1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover
Altman Z-Score 2.91 — Grey Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Undervalued

MetricStockSectorvs Peers
P/E Ratio 13.9 22.0 -37% below
P/B Ratio -14.2 4.0 Inline
Dividend Yield 76.0% 1.5% Above avg

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Intrinsic Value (DCF) Fairly Valued

Intrinsic Value
395.86
vs
Market Price
403.22
Upside
-1.8%
Margin of Safety -1.9%
Stage 1 PV (5yr FCF)22,621,055,541
Terminal Value PV65,196,701,680
Total Enterprise Value87,817,757,221

Assumptions

Base FCF5,153,782,234
Growth Rate (5yr)4.3%
Terminal Growth2.5%
Discount Rate (WACC)9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.8%
Recommended Size
29.81%
Full Kelly
14.91%
Half Kelly
5.0%
Max Cap (Moderate)

Kelly inputs derived from quant score 46/100. Estimated win rate 54%, avg win 7.8%, avg loss 4.1%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

RECOVERY Regime: RECOVERY (20% confidence) — position size reduced 4%

Signal Summary BUY

2
Bullish Signals
2
Bearish Signals
53.25
RSI(14)
4.1306
MACD

Relative Strength (RS) WEAK RS

35
/ 99
RS Rating
O'Neil filter: <80
RS vs SPY ↓ FALLING (-31.1% vs SPY 3M)
RS vs Sector UNDERPERFORMING (Healthcare)
RS New High No (62d since high)
Sector Outperformance -25.6% (3M)
RS Line — stock / SPY (90 bars)
← older newer →
RS vs SPY 50-day SMA of RS
WEAK RS: Underperformer — the stock is lagging the market. Avoid until RS trend reverses upward.

Technical Indicators

IndicatorValueSignal
Rsi 53.25 NEUTRAL
Macd 4.1306 BULLISH
Ma Cross 399.27 / 458.56 DEATH CROSS
Trend Short ABOVE SMA50
Trend Long BELOW SMA200
Bollinger MIDDLE
Volume 0.37x LOW

Key Levels

LevelPrice
52-Week High556.52
Bollinger Upper421.56
SMA(200)458.56
SMA(50)399.27
SMA(20)394.67
Current Price403.22
Bollinger Lower367.78
52-Week Low330.00
ATR(14)11.25

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

MARKDOWN Confidence
100%
Acc: 0.0  |  Dist: 0.0  |  Markup: 0.0  |  Markdown: 2.0

Volume Spread Analysis (last 5 bars)

DateSignalVolDescription
2026-07-06 Normal 0.86x Normal bar — no special VSA pattern
2026-07-07 Normal 0.99x Normal bar — no special VSA pattern
2026-07-08 Normal 1.12x Normal bar — no special VSA pattern
2026-07-09 Normal 0.71x Normal bar — no special VSA pattern
2026-07-10 Normal 0.37x Normal bar — no special VSA pattern

Ichimoku Cloud NEUTRAL

LineValueStatus
Tenkan-sen (9) 406.77 Above Kijun
Kijun-sen (26) 392.86 Base line
Senkou A 399.81 Leading span A
Senkou B 403.83 Leading span B
Cloud 399.81 – 403.83 Bearish (Red)
Price vs Cloud 403.69 Inside Cloud
Chikou Span 362.50 Bullish
Alignment Score 2/4 NEUTRAL

TTM Squeeze & Divergences

TTM Squeeze

SQUEEZE OFF No squeeze Momentum: BULLISH FADING
BB: 367.78 – 421.56  |  KC: 378.48 – 410.85

Divergences (last 60 bars)

TypeIndicatorBars AgoStrength
Hidden Bearish RSI 17

Anchored VWAP

VWAP: 440.36 Anchor: 2025-07-25 (52w Low) BELOW AVWAP -8.3%

Heikin-Ashi Trend

BEARISH Full data via /api/advanced/HCA

Valuation

MetricValue
Market Cap89.45B
P/E (TTM)13.88
Forward P/EN/A
P/B-14.24
EPS29.04

Financial Health

MetricValue
Revenue Growth4.3%
Profit Margin8.9%
ROEN/A
Debt/EquityN/A
Current Ratio0.83
Dividend Yield76.0%
Payout RatioN/A
Beta1.13

Trading Data

403.22
Open
403.22
Day High
403.22
Day Low
522.4K
Volume (0.3x avg)

Recent News (8)

HCA Healthcare (HCA) Could Be 35% Undervalued Following Downgrades And Index Exits
Simply Wall St. · 2026-07-09
HCA Healthcare (HCA) Publishes Gene Editing Research For Children With Severe Blood Disorders
Simply Wall St. · 2026-07-09
Sector Update: Healthcare Stocks Decline Late Afternoon
MT Newswires · 2026-07-08
Is the Options Market Predicting a Spike in HCA Healthcare Stock?
Zacks · 2026-07-08
Dollar Tree upgraded, PayPal initiated: Wall Street's top analyst calls
The Fly · 2026-07-08
HCA Healthcare (HCA): Buy, Sell, or Hold Post Q1 Earnings?
StockStory · 2026-07-08
Here Are Wednesday’s Best Wall Street Analyst Research Calls: Alcoa, Commercial Metals, DTE Energy, Dollar Tree, Occidental Petroleum, PayPal, Pinterest, Snap, Travelers, and More
24/7 Wall St. · 2026-07-08
Your Hospital’s HR Won’t Tell You This: Nurses Can Legally Shield $49,000 a Year by Stacking a 403(b) and a 457(b)
24/7 Wall St. · 2026-07-07

Price Chart (90 Days)

Candlesticks (green=up, red=down) SMA 20 SMA 50 Bollinger Bands (upper/lower) Volume (green=buying, red=selling)
Powered by Fahodi Methodology. This is analytical output, not financial advice. Always do your own due diligence.  ·  Pipeline status  ·  Data: —